1. Home
  2. TVTX vs BLMN Comparison

TVTX vs BLMN Comparison

Compare TVTX & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • BLMN
  • Stock Information
  • Founded
  • TVTX 2008
  • BLMN 1988
  • Country
  • TVTX United States
  • BLMN United States
  • Employees
  • TVTX N/A
  • BLMN N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • BLMN Restaurants
  • Sector
  • TVTX Health Care
  • BLMN Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • BLMN Nasdaq
  • Market Cap
  • TVTX 1.6B
  • BLMN 1.4B
  • IPO Year
  • TVTX N/A
  • BLMN 2012
  • Fundamental
  • Price
  • TVTX $17.49
  • BLMN $12.55
  • Analyst Decision
  • TVTX Buy
  • BLMN Hold
  • Analyst Count
  • TVTX 13
  • BLMN 11
  • Target Price
  • TVTX $23.46
  • BLMN $18.00
  • AVG Volume (30 Days)
  • TVTX 1.1M
  • BLMN 1.7M
  • Earning Date
  • TVTX 02-13-2025
  • BLMN 11-08-2024
  • Dividend Yield
  • TVTX N/A
  • BLMN 7.62%
  • EPS Growth
  • TVTX N/A
  • BLMN N/A
  • EPS
  • TVTX N/A
  • BLMN N/A
  • Revenue
  • TVTX $203,447,000.00
  • BLMN $4,547,161,000.00
  • Revenue This Year
  • TVTX $62.17
  • BLMN N/A
  • Revenue Next Year
  • TVTX $56.38
  • BLMN N/A
  • P/E Ratio
  • TVTX N/A
  • BLMN N/A
  • Revenue Growth
  • TVTX 57.08
  • BLMN N/A
  • 52 Week Low
  • TVTX $5.12
  • BLMN $12.18
  • 52 Week High
  • TVTX $20.33
  • BLMN $30.13
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 39.02
  • BLMN 40.40
  • Support Level
  • TVTX $17.27
  • BLMN $12.42
  • Resistance Level
  • TVTX $19.20
  • BLMN $13.09
  • Average True Range (ATR)
  • TVTX 0.72
  • BLMN 0.52
  • MACD
  • TVTX -0.29
  • BLMN 0.05
  • Stochastic Oscillator
  • TVTX 3.80
  • BLMN 15.22

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: